https://imcjms.com Ibrahim Medical College Journal of Medical Science https://imcjms.com/registration/journal_full_text/571 Mon, 28 Jul 2025 12:53:00 +0000 Abstract Background and objectives: Despite being a definite endemic zone for melioidosis, very few cases have been reported from Bangladesh. Lack of awareness among clinicians, microbiologists and medical technologists might be a major concern. To combat this, a training workshop was launched to refine diagnostic and management skills among healthcare professionals of Bangladesh. Materials and methods: Initially, a pre-test was conducted with a questionnaire containing 20 multiple choice questions focusing on epidemiology, diagnosis and management of Burkholderia pseudomallei infection. Following the pre-test, training sessions containing lectures on melioidosis (including video demonstration) were held and at the end of the sessions, assessment of the knowledge was acquired by a post-test with the same questionnaire. Results: A total of 113 clinicians, microbiologists and medical technologists from 20 public and private medical college and hospitals around Bangladesh participated in pre-test and 87 in post-test after the workshop. Our results documented that the mean percentage of pre-test score was 62.4 ± 22.9 which indicates a considerable gap of knowledge among healthcare professionals regarding melioidosis and B. pseudomallei. The mean percentage of post-test score significantly (p = 0.0001) increased to 79.2 ± 16.5 after the training session. Conclusion: Awareness and skill development programs could play vital role to reduce the knowledge gaps among health care providers about melioidosis. This will increase the yield of diagnosis of this notorious infection and many lives could be saved. July 2025; Vol. 19(2):005.  DOI: https://doi.org/10.55010/imcjms.19.014 *Correspondence: Sraboni Mazumder, Department of Microbiology, Ibrahim Medical College, 1/A Segunbagicha Road, Dhaka-1000 Bangladesh. E-mail: mazumder.sraboni@gmail.com. © 2025 The Author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License(CC BY 4.0).   Introduction Melioidosis is a neglected tropical disease (NTD) caused by a highly pathogenic gram-negative bacterium, Burkholderia pseudomallei (BP), and is an important cause of sepsis globally [1,2]. Although the disease is endemic in Southeast Asia and northern Australia, many cases have also been reported in non-endemic zones [3,4]. About 20% of community-acquired sepsis in Thailand is caused by melioidosis, and around 2,000 to 3,000 new cases are detected each year [5,6]. However, the true global burden of melioidosis remains poorly understood due to a large number of undetected cases in endemic regions [7]. In 2011, B. pseudomallei was first isolated from soil in different regions of Bangladesh, and since then, the country has been considered a definite endemic zone for melioidosis [8,9]. A regression model estimated approximately 16,931 cases annually with a mortality rate of 56% (around 9,500 deaths) in Bangladesh [7]. Despite this, only a few cases have been reported so far [8]. Several small-scale awareness activities and isolated training efforts have been undertaken in Bangladesh to address this gap. However, these programs have often lacked nationwide coverage, consistent reinforcement, or structured follow-up, which limits their long-term impact. Consequently, awareness and diagnostic capacity among healthcare professionals remain inadequate, resulting in underreporting and misdiagnosis of melioidosis cases. Similar gaps in knowledge and awareness have also been observed in other endemic countries such as Thailand and northern Australia, where comprehensive, repeated training and targeted community awareness programs have shown to be effective in improving diagnosis and management of melioidosis [10,11]. To help bridge this gap in Bangladesh, our study aimed to conduct a pre-test and post-test assessment of knowledge on melioidosis among healthcare providers following a virtual training workshop. The objectives were to evaluate baseline knowledge among clinicians, microbiologists, and medical technologists, provide targeted training, and assess knowledge improvement after the program. The training was organized through collaboration among the Centers for Disease Control and Prevention (CDC), Ibrahim Medical College, BIRDEM General Hospital, Bangabandhu Sheikh Mujib Medical University, and the Bangladesh Society of Tropical and Infections Disease (BSTID), supported by the CDC-HSP capacity development project on melioidosis. The findings of this study can guide the design of future awareness and capacity-building campaigns to improve diagnosis and management of this neglected but potentially deadly infection.   Materials and methods The study was designed as a pre- and post-test study and conducted online through the Zoom Cloud Meetings application during the COVID-19 pandemic. A structured questionnaire containing 20 multiple-choice questions (MCQs) was prepared and validated by experienced clinicians and microbiologists specializing in melioidosis. The questionnaire focused on the epidemiology, diagnosis, and management of Burkholderia pseudomallei. A total of 113 clinicians, microbiologists, and medical technologists from 20 public and private medical colleges and hospitals in 13 districts participated in the pre-test before the training program. The training consisted of a four-day series of interactive lectures delivered via Zoom using PowerPoint presentations and video demonstrations, followed by interactive question-answer sessions. Participation was tracked through Zoom attendance records and submission of responses via Google Forms. The same questionnaire was administered as a post-test at the end of the training to assess knowledge retention.   Results Pre-and post-test questionnaires included 20 multiple choice questions to test knowledge of healthcare professionals regarding melioidosis. A total of 113 participants responded to the pre-test questionnaires, while only 87 of them attended the post-test questionnaire, indicating a post-test dropout rate of approximately 23%. Male (61, 54%) participants were more in number than female (52, 46%). More than half of the participants (64, 56.6%) were microbiologists, followed by 33 (29.2%) clinicians, and 16 (14.2%) medical technologists. The gender distribution of the participants and their occupation are shown in Table-1. Answering patterns to the questions are shown in Table-2.   Table-1: Gender and occupation of the study population (N = 113)     Epidemiology of Burkholderia pseudomallei: During pre-test, 98.1% of the respondents could identify that BP is the causative agent of melioidosis and 98.1% could state that the organism is a bacterium. Only 60.2% of the responders knew that Bangladesh is a definite endemic country for melioidosis on pre-test. Most participants (90.8%) could correctly identify skin penetration as one of the routes of transmissions. Nevertheless, ingestion (66.3%) and inhalation (83.2%) were not known to be common routes of transmission, which showed promising improvement on post-test. Most of the participants could state that soil exposure (97.1%) is a source of infection. However, the majority of the respondents did not know of food (65%) and cattle (74.7%) as the sources of BP infection. Many respondents were not aware that dog and pig can also be infected by this bacterium and were ameliorated (51.9% and 83.1% respectively) after the training session on post-test. Almost all participants (98.9%) could answer correctly that agricultural workers are the high-risk group for melioidosis on post-test, whereas only 35.1% of the participants were aware of construction workers as high-risk population. Thalassemia, as a common co-morbid association with melioidosis, was commonly missed by 48.3% of the participants, which showed better results on post-test (28%). Clinical and laboratory diagnosis of Burkholderia pseudomallei infection: Participants on pre-test knew that melioidosis can present with abscess (97%), pneumonia (92.9%), septicemia (89.7%), and septic arthritis (70.2%); however, only 40.7% of them could answer that BP may also present with urinary tract infection. Participants’ knowledge on these variables was developed further after the training session. Most of the participants were well oriented that blood, sputum, pus, joint fluid and urine samples could yield to growth of BP for laboratory diagnosis. More than 97% of the health care workers of this study knew that culture is the gold standard laboratory test for the diagnosis of melioidosis; 87.4% stated correctly about the safety pin appearance of the bacteria in Gram stain and 91.7% knew Ashdown agar media is the selective media for isolation of this organism. Nonetheless, only 34.1% health care workers answered correctly on pre-test that MacConkey’s agar media is a selective media for isolation of the organism and was improved to 41.8% on post-test. More than 90% heath care personnel mentioned tuberculosis as a differential diagnosis of melioidosis; on the other hand, only a negligible proportion of participants (20%) identified typhoid as a differential diagnosis for melioidosis, which increased to 39% on post-test. However, whereas 70% of the participants and 48.8% participants could identify brucellosis and leptospirosis as differentials for melioidosis in the pre-test, the post-test percentage was much lower (55.4% and 35.1% respectively). The participants’ knowledge on case fatality rate of melioidosis was also very low in both pre-test and post-test. Management of melioidosis: Majority of participants knew that melioidosis requires prolonged antibiotic therapy for three or more months. More than 90% of the responders could reply correctly on intrinsic antibiotic resistance pattern of BP on post-test (> 67% on pre-test). Majority of the participants had the knowledge regarding ceftazidime (90.3%) and meropenem (83.5%) being sensitive to BP as well as drug of choice for melioidosis, which also was seen to be enhanced after the training session (96.5% and 97.7% respectively).   Table-2: Correct responses to the questions before and after the training amongst the participants   BP has a unique sensitivity pattern to certain antibiotics. It is sensitive to ceftazidime, meropenem, imipenem and co-amoxiclav, doxycycline, trimethoprim-sulfamethoxazole. On the other hand, it exhibits intrinsic resistance to penicillin, aminoglycosides, first and second generation cephalosporins, macrolides, and colistin [21,22]. More than 30% respondents erroneously indicated cotrimoxazole as resistant drug for melioidosis. In addition, 31.7% of health care personnel did not know that ceftriaxone is not an appropriate choice of antibiotic to treat melioidosis and more than one-third of participants had misconception regarding co-amoxiclav which can be used to treat melioidosis patient. This knowledge gap might create difficulty in treating patients appropriately and contribute to higher mortality rates. Therefore, during the training session, elaborative lectures on these specific topics were ensured to help the participants improvise their knowledge gaps. The participants came into consensus that, while reporting a culture, it should be mentioned that only carbapenems and ceftazidime shall be prescribed for intensive phase. The antibiotic choice for maintenance phase also needs to be notified in the culture report. Pre- and post-test studies are done mainly to assess the impact of an intervention among a group of people. Our study has concluded with significant improvement in knowledge regarding epidemiology, risk factors, clinical presentation, laboratory diagnosis, and management of melioidosis on post-test compared with the pre-test scores. However, there was low retention of knowledge regarding the case fatality rate, differential diagnoses, and high-risk population identification regarding melioidosis. To address these gaps, future workshops and in-person training sessions can be organized to provide more interactive learning and practical discussion, which may help improve knowledge on case fatality rate, differential diagnosis, and high-risk populations.In a previous study conducted in Thailand, video clips were found to be more beneficial in increasing adherence among the participants and could positively influence their awareness regarding preventive behaviors for melioidosis [23]. Hence, audio-visual representation of the preventive measures could be a potential mode of raising awareness of this NTD among healthcare workers, as well as the general population. Awareness campaigns are very crucial to refine knowledge about the infectious diseases in tropical regions. This is the key to improving the diagnostic yield, and treatment modalities, as well as reducing mortality of medically important NTDs like melioidosis in endemic zones.   Conclusion Increasing knowledge through training among clinicians, microbiologists and lab personnel is a vital tool to control melioidosis in our country. To increase awareness among healthcare providers, it is mandatory to organize effective education campaigns and hospital-based training program all over the country. This will not only aid in circulating knowledge, but also improvise the diagnostic and management skills of the skilled professionals. We suggest dissemination of knowledge about epidemiology, diagnosis and management of BP to health professionals through regular hands-on training programs.   Limitations We believe our study has certain limitations. First, the sample size was very small. Larger studies can be done in future to critically compare pre-test and post-test performance. Secondly, only 87 out of 113 people participated in post-test assessment. Thirdly, as the session was carried out online, the level of engagement of the participants could not be evaluated although, the performance improvement in post-test analysis indicates towards sufficient engagement of the respondents. Assessing after six months could give a better retention status, which should be considered in future. Abbreviations- NTD: Neglected Tropical Disease; BP: Burkholderia pseudomallei; CDC: Centers for Disease Control and Prevention; BSTID: Bangladesh Society of Tropical and Infections Disease; BSMM: Bangladesh Society of Medical Microbiologists; CDC-HSP: Centers for Disease Control and Prevention-Health Security Partners.   Acknowledgements We acknowledge CDC-HSP (Centers for Disease Control and Prevention-Health Security Partners) capacity development project on melioidosis in Bangladesh for funding this project. We acknowledge Prof. David Dance, Prof. Chiranjay Mukhopadhyay, Prof. M A Faiz, Prof. Jalaluddin Ashraful Haq, Prof. Md. Ruhul Amin, Prof. Ahmed Abu Saleh and Prof. Md Robed Amin for their participation in the workshop and deliberation of expert comments. We are also grateful to Prof. Md Nazmul Islam, Director CDC, DGHS, Government of Bangladesh and his office to support this project.   Author contributions Sraboni Mazumder: Investigation, Formal analysis, Project administration, Writing – original draft, Writing – review and editing. Tabiha Binte Hannan: Formal analysis, Writing – review and editing. Fahmida Rahman: Investigation, Formal Analysis, Writing – review and editing. Saika Farook: Investigation, Project administration. Forhad Uddin Hasan Chowdhury: Investigation, Project administration. Lovely Barai: Investigation, Project administration, Writing – review and editing. Chandan Kumar Roy: Investigation, Project administration, Writing – review and editing. Kutub Uddin Ahamed: Investigation, Project administration. Md. Shariful Alam Jilani: Conceptualization, Investigation, Project administration, Writing – review and editing. Fazle Rabbi Chowdhury: Conceptualization, Methodology, Project administration, Formal analysis, Writing – review and editing.   Funding Not applicable.   Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.   Ethics approval and consent to participants Informed consent was taken from all participants.   References 1.     Keluangkhot V, Pethsouvanh R, Strobel M. Mélioïdose [Melioidosis].Med Mal Infect. 2005; 35(10): 469-475. doi:10.1016/j.medmal.2005.08.001. 2.     Ganesan V, Sundaramoorthy R, Subramanian S. Melioidosis-Series of Seven Cases from Madurai, Tamil Nadu, India. Indian J Crit Care Med. 2019; 23(3): 149-151. doi:10.5005/jp-journals-10071-23139. 3.     Mukhopadhyay C, Shaw T, Varghese GM, Dance DAB. Melioidosis in South Asia (India, Nepal, Pakistan, Bhutan and Afghanistan). Trop Med Infect Dis. 2018; 3(2): 51. doi:10.3390/tropicalmed3020051. 4.     Currie BJ, Dance DA, Cheng AC. The global distribution of Burkholderia pseudomallei and melioidosis: an update.Trans R Soc Trop Med Hyg. 2008; 102 Suppl 1: S1-S4. doi:10.1016/S0035-9203(08)70002-6. 5.     Chaowagul W, White NJ, Dance DA, Wattanagoon Y, Naigowit P, Davis TM, et al. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis. 1989; 159(5): 890-899. doi:10.1093/infdis/159.5.890. 6.     Limmathurotsakul D, Wongratanacheewin S, Teerawattanasook N, Wongsuvan G, Chaisuksant S, Chetchotisakd P, et al. Increasing incidence of human melioidosis in Northeast Thailand.Am J Trop Med Hyg. 2010; 82(6): 1113-1117. doi:10.4269/ajtmh.2010.10-0038. 7.     Limmathurotsakul D, Golding N, Dance DA, Messina JP, Pigott DM, Moyes CL, et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol. 2016; 1(1): 15008. doi:10.1038/nmicrobiol.2015.8. 8.     Chowdhury FR, Roy CK, Barai L, Paul S, Chowdhury FUH, Mazumder S, et al. Melioidosis: A neglected infection in Bangladesh. J Med. 2021; 22: 139–145. doi:10.3329/jom.v22i2.56705. 9.     Jilani MSA, Robayet JAM, Mohiuddin M, Hasan MR, Ahsan CR, Haq JA. Burkholderia pseudomallei: Its detection in soil and seroprevalence in Bangladesh. PLoS Negl Trop Dis. 2016; 10(1): e0004301. doi:10.1371/journal.pntd.0004301. 10. Weeratunga MP, Mayo M, Kaestli M, Currie BJ. Melioidosis knowledge awareness in three distinct groups in the tropical northern territory of Australia. Trop Med Infect Dis. 2024; 9(4): 71. doi:10.3390/tropicalmed9040071. 11.  Smith S, Buikstra E, Rubenach S, Preston-Thomas A, Hanson J. Limited awareness of melioidosis in high-risk populations despite an increasing incidence of the disease in Far North Queensland, Australia. Am J Trop Med Hyg. 2022; 107(6): 1278-1280. doi:10.4269/ajtmh.22-0160. 12. Almarhabi H, Munshi A, Althobaiti M, AljohaniS, Abu Shanab R, Althaqafi A. Melioidosis pneumonia in Saudi Arabia: A rare case report and review of the literature. Cureus. 2022; 14(2): e21871. doi:10.7759/cureus.21871. 13. Wiersinga WJ, Virk HS, Torres AG, Currie BJ, Peacock SJ, Dance DAB, et al. Melioidosis. Nat Rev Dis Primers. 2018; 4: 17107. doi:10.1038/nrdp.2017.107. 14. Chowdhury S, Barai L, Afroze SR, Ghosh PK, Afroz F, Rahman H, et al. The epidemiology of melioidosis and its association with diabetes mellitus: A systematic review and meta-analysis. Pathogens. 2022; 11(2): 149. doi:10.3390/pathogens11020149. 15. Hemarajata P, Baghdadi JD, Hoffman R, Humphries RM. Burkholderia pseudomallei: Challenges for the clinical microbiology laboratory. J Clin Microbiol. 2016; 54(12): 2866-2873. doi:10.1128/JCM.01636-16. 16. Gassiep I, Armstrong M, Norton R. Human Melioidosis. Clin Microbiol Rev. 2020; 33(2): e00006-19. doi:10.1128/CMR.00006-19. 17. Peeters M, Ombele S, Chung P, Tsoumanis A, Lim K, Long L, et al. Slow growth of Burkholderia pseudomallei compared to other pathogens in an adapted blood culture system in Phnom Penh, Cambodia. J Med Microbiol. 2019; 68(8): 1159-1166. doi:10.1099/jmm.0.001011. 18. Wuthiekanun V, Dance DA, Wattanagoon Y, Supputtamongkol Y, Chaowagul W, White NJ. The use of selective media for the isolation of Pseudomonas pseudomallei in clinical practice.J Med Microbiol. 1990; 33(2): 121-126. doi:10.1099/00222615-33-2-121. 19. Chowdhury FR, Jilani MSA, Barai L, Rahman T, Saha MR, Amin MR, et al. Melioidosis in Bangladesh: A clinical and epidemiological analysis of culture-confirmed cases. Trop Med Infect Dis. 2018; 3(2): 40. doi:10.3390/tropicalmed3020040. 20.  Tauran PM, Wahyunie S, Saad F, Dahesihdewi A, Graciella M, Muhammad M, et al. Emergence of melioidosis in Indonesia and today's challenges. Trop Med Infect Dis. 2018; 3(1): 32. doi:10.3390/tropicalmed3010032. 21.  Hassan MR, Vijayalakshmi N, Pani SP, Peng NP, Mehenderkar R, Voralu K, et al. Antimicrobial susceptibility patterns of Burkholderia pseudomallei among melioidosis cases in Kedah, Malaysia. Southeast Asian J Trop Med Public Health. 2014; 45(3): 680-688. 22.  Crowe A, McMahon N, Currie BJ, Baird RW. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia. Int J Antimicrob Agents. 2014; 44(2):160-162. doi:10.1016/j.ijantimicag.2014.04.012. 23.  Chansrichavala P, Wongsuwan N, Suddee S, Malasit M, Hongsuwan M, Wannapinij P, et al. Public awareness of melioidosis in Thailand and potential use of video clips as educational tools. PLoS One. 2015; 10(3): e0121311. doi:10.1371/journal.pone.0121311.     Cite this article as: Mazumder S, Hannan TB, Rahman F, Farook S, Chowdhury FUH, Barai L, et al. Knowledge on melioidosis among healthcare workers of Bangladesh. IMC J Med Sci. 2025; 19(2):005. DOI:https://doi.org/10.55010/imcjms.19.014 2026 Ibrahim Medical College. All rights reserved.